Hilltop Bio Overview
- Year Founded
-
2018
- Status
-
Private
- Employees
-
10
- Latest Deal Type
-
Series A
- Latest Deal Amount
-
$5.3M
- Investors
-
14
Hilltop Bio General Information
Description
Operator of a veterinary biotechnology company intended to develop innovative cell signaling therapies to help reduce animal inflammation. The company identifies key inflammatory diseases in companion and performance animals and works to provide targeted treatments to help reduce inflammation and normalize damaged tissue function, enabling animal owners to get fast and efficient healing for horses and dogs suffering from several conditions.
Contact Information
Website
www.hilltopbio.comCorporate Office
- 320 Norwood Park South
- Suite 202
- Norwood, MA 02062
- United States
Corporate Office
- 320 Norwood Park South
- Suite 202
- Norwood, MA 02062
- United States
Hilltop Bio Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Later Stage VC (Series A) | 31-Mar-2025 | $5.3M | Completed | Generating Revenue | ||
| 3. Early Stage VC (Series A) | 04-Oct-2021 | Completed | Generating Revenue | |||
| 2. Seed Round | 02-Jul-2019 | $751K | $751K | Completed | Generating Revenue | |
| 1. Accelerator/Incubator | Completed | Generating Revenue |
Hilltop Bio Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A-3 | ||||||||
| Series A-2 | ||||||||
| Series A-1 | ||||||||
| Series A | 377,644 | $0.000100 | $4.13 | $4.13 | 1x | $4.13 | 11.1% | |
| Seed | 272,412 | $0.000100 | $2.76 | $2.76 | 1x | $2.76 | 8% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Hilltop Bio Comparisons
Industry
Financing
Details
Hilltop Bio Competitors (3)
One of Hilltop Bio’s 3 competitors is Diamond V, a Corporate Backed or Acquired company based in Cedar Rapids, IA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Diamond V | Corporate Backed or Acquired | Cedar Rapids, IA | ||||
| AniCell Biotech | Corporation | Chandler, AZ | ||||
| Bactana | Formerly VC-backed | Farmington, CT |
Hilltop Bio Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Hilltop Bio Patents
Hilltop Bio Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-12226438-B2 | System and method for therapeutic compositions from a plurality of different birth tissues and exosomes | Active | 18-Jun-2021 | ||
| US-20220401496-A1 | System and method for therapeutic compositions from a plurality of different birth tissues and exosomes | Active | 18-Jun-2021 | ||
| US-20250235487-A1 | System and method for therapeutic compositions from a plurality of different birth tissues and exosomes | Pending | 18-Jun-2021 | ||
| WO-2022265890-A1 | System and method for therapeutic compositions from a plurality of different birth tissues and exosomes | Inactive | 18-Jun-2021 | ||
| US-11975136-B2 | System and method for aseptic collection of mammalian amniotic fluid | Active | 15-Sep-2020 | A61M1/87 |
Hilltop Bio Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Hilltop Bio Investors (14)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Ag Startup Engine | Venture Capital | Minority | ||
| Band of Angels | Angel Group | Minority | ||
| Beacon Angels | Angel Group | Minority | ||
| Frontier Angels | Angel Group | Minority | ||
| Mid Atlantic Bio Angels | Angel Group | Minority |
Hilltop Bio FAQs
-
When was Hilltop Bio founded?
Hilltop Bio was founded in 2018.
-
Where is Hilltop Bio headquartered?
Hilltop Bio is headquartered in Norwood, MA.
-
What is the size of Hilltop Bio?
Hilltop Bio has 10 total employees.
-
What industry is Hilltop Bio in?
Hilltop Bio’s primary industry is Biotechnology.
-
Is Hilltop Bio a private or public company?
Hilltop Bio is a Private company.
-
What is the current valuation of Hilltop Bio?
The current valuation of Hilltop Bio is .
-
What is Hilltop Bio’s current revenue?
The current revenue for Hilltop Bio is .
-
How much funding has Hilltop Bio raised over time?
Hilltop Bio has raised $8.05M.
-
Who are Hilltop Bio’s investors?
Ag Startup Engine, Band of Angels, Beacon Angels, Frontier Angels, and Mid Atlantic Bio Angels are 5 of 14 investors who have invested in Hilltop Bio.
-
Who are Hilltop Bio’s competitors?
Diamond V, AniCell Biotech, and Bactana are competitors of Hilltop Bio.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
